APOC1 as a novel diagnostic biomarker for DN based on machine learning algorithms and experiment .
- Published in:
- Frontiers in Endocrinology, 2023, v. 14, p. 1, doi. 10.3389/fendo.2023.1102634
- By:
- Publication type:
- Article
Works matching AU Yu, Kuipeng
Results: 4
1
2
Identification and validation of P4HB as a novel autophagy-related biomarker in diabetic nephropathy.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.965816
- By:
- Publication type:
- Article
3
Blockade of aryl hydrocarbon receptor restricts omeprazole-induced chronic kidney disease.
- Published in:
- Journal of Molecular Medicine, 2024, v. 102, n. 5, p. 679, doi. 10.1007/s00109-024-02429-5
- By:
- Publication type:
- Article
4
APOC1 exacerbates renal fibrosis through the activation of the NF-κB signaling pathway in IgAN.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1181435
- By:
- Publication type:
- Article